Narcolepsy With Cataplexy Clinical Trial
Official title:
Double Blind, Multicentre, Randomized, Placebo-controlled Trial to Evaluate Safety and Efficacy of Pitolisant in Children From 6 to Less Than 18 Years With Narcolepsy With/Without Cataplexy, Followed by a Prolonged Open-label Period
The purpose of this multicenter double blind study is to assess efficacy and safety of Pitolisant versus placebo in paediatric Narcoleptic patients with or without cataplexy.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04026958 -
Clarithromycin Mechanisms in Hypersomnia Syndromes
|
Phase 2 | |
Completed |
NCT05055024 -
An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy
|
Phase 2 | |
Suspended |
NCT04419792 -
'A Profile of Physical Performance Variables in an Out-patient Adult Population With Narcolepsy'
|
||
Completed |
NCT02221869 -
A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy
|
Phase 3 | |
Completed |
NCT03030599 -
A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy
|
Phase 3 | |
Completed |
NCT04306952 -
Awareness and Self-Compassion Enhancing Narcolepsy Treatment
|
N/A | |
Not yet recruiting |
NCT06383806 -
Decreasing Nightmares in Adults With Narcolepsy
|
N/A | |
Not yet recruiting |
NCT05914194 -
A Eight-Week Study of NLS-2 (Mazindol Extended Release) in Participants With Narcolepsy Type 1
|
Phase 3 | |
Completed |
NCT02637076 -
Xyrem and Brain Dopamine in Narcolepsy
|
Phase 4 | |
Completed |
NCT05709873 -
Narcolepsy Nightmare Study
|
N/A | |
Completed |
NCT01800045 -
Pitolisant to Assess Weekly Frequency of Cataplexy Attacks and EDS in Narcoleptic Patients (HARMONY CTP)
|
Phase 3 | |
Completed |
NCT00345800 -
Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes
|
Phase 1 | |
No longer available |
NCT03433131 -
Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy
|